Published in Ann Intern Med on February 20, 2007
Comparative Effectiveness of FITs With Colonoscopy | NCT03264898
Canadian Association of Gastroenterology position statement on screening individuals at average risk for developing colorectal cancer: 2010. Can J Gastroenterol (2010) 3.20
Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis. BMJ (2010) 2.94
Analysis of fecal DNA methylation to detect gastrointestinal neoplasia. J Natl Cancer Inst (2009) 2.57
Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer (2009) 1.93
Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med (2014) 1.68
Tailoring colorectal cancer screening by considering risk of advanced proximal neoplasia. Am J Med (2012) 1.54
Colorectal cancer screening for average-risk North Americans: an economic evaluation. PLoS Med (2010) 1.51
Colorectal cancer: from prevention to personalized medicine. World J Gastroenterol (2014) 1.26
Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme. Br J Cancer (2009) 1.24
Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT). Gut Liver (2014) 1.19
The sensitivity and specificity of guaiac and immunochemical fecal occult blood tests for the detection of advanced colonic adenomas and cancer. Int J Colorectal Dis (2012) 1.08
Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Br J Cancer (2009) 1.06
Change to FIT increased CRC screening rates: evaluation of a US screening outreach program. Am J Manag Care (2012) 1.05
Potential of soluble CD26 as a serum marker for colorectal cancer detection. World J Clin Oncol (2011) 1.04
Screening for colorectal cancer: established and emerging modalities. Nat Rev Gastroenterol Hepatol (2011) 0.99
Sensitivity of immunochemical faecal occult blood testing for detecting left- vs right-sided colorectal neoplasia. Br J Cancer (2011) 0.99
Colorectal cancer screening: tests, strategies, and perspectives. Front Public Health (2014) 0.99
Early detection of and screening for colorectal neoplasia. Gut Liver (2009) 0.97
Uptake and positive predictive value of fecal occult blood tests: A randomized controlled trial. Prev Med (2013) 0.97
Fecal immunochemical test accuracy in average-risk colorectal cancer screening. World J Gastroenterol (2014) 0.96
Advances in Fecal Occult Blood Tests: the FIT revolution. Dig Dis Sci (2014) 0.95
Double sampling of a faecal immunochemical test is not superior to single sampling for detection of colorectal neoplasia: a colonoscopy controlled prospective cohort study. BMC Cancer (2011) 0.92
Cost-effectiveness of a mailed educational reminder to increase colorectal cancer screening. BMC Gastroenterol (2011) 0.92
Comparison of a guaiac and an immunochemical faecal occult blood test for the detection of colonic lesions according to lesion type and location. Br J Cancer (2009) 0.91
Quantitative immunochemical fecal occult blood tests: is it time to go back to the future? Ann Intern Med (2007) 0.91
Implications of new colorectal cancer screening technologies for primary care practice. Med Care (2008) 0.87
Population-based colorectal cancer screening: comparison of two fecal occult blood test. Front Pharmacol (2014) 0.86
Similar fecal immunochemical test results in screening and referral colorectal cancer. World J Gastroenterol (2012) 0.86
Prediction of flare-ups of ulcerative colitis using quantitative immunochemical fecal occult blood test. World J Gastroenterol (2010) 0.85
Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol (2016) 0.85
Improving CRC screening requires innovative approaches: can electronic medical records help? Am J Prev Med (2008) 0.81
A simplified, non-invasive fecal-based DNA integrity assay and iFOBT for colorectal cancer detection. Int J Colorectal Dis (2011) 0.81
Test characteristics of faecal immunochemical tests (FIT) compared with optical colonoscopy. J Med Screen (2014) 0.81
Development of new non-invasive tests for colorectal cancer screening: the relevance of information on adenoma detection. Int J Cancer (2014) 0.81
Developments in Screening Tests and Strategies for Colorectal Cancer. Biomed Res Int (2015) 0.80
Impact of faecal haemoglobin concentration on colorectal cancer mortality and all-cause death. BMJ Open (2013) 0.80
Colorectal cancer screening in an equal access healthcare system. J Cancer (2013) 0.80
Diagnostic accuracy of fecal immunochemical test in average- and familial-risk colorectal cancer screening. United European Gastroenterol J (2014) 0.80
Complementary Glycomic Analyses of Sera Derived from Colorectal Cancer Patients by MALDI-TOF-MS and Microchip Electrophoresis. Anal Chem (2016) 0.78
The sensitivity, specificity, predictive values, and likelihood ratios of fecal occult blood test for the detection of colorectal cancer in hospital settings. Clin Exp Gastroenterol (2015) 0.78
Is a fecal occult blood test a useful tool for judging whether to perform capsule endoscopy in low-dose aspirin users with negative colonoscopy and esophagogastroduodenoscopy? J Gastroenterol (2016) 0.78
Evaluation of fecal immunochemical tests for colorectal cancer screening. J Prim Care Community Health (2013) 0.78
The Diagnostic Accuracy of the M2 Pyruvate Kinase Quick Stool Test--A Rapid Office Based Assay Test for the Detection of Colorectal Cancer. PLoS One (2015) 0.78
Current noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening tests. World J Gastrointest Oncol (2016) 0.77
Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results? Yonsei Med J (2017) 0.77
Use of a low cut-off value for the fecal immunochemical test enables better detection of proximal neoplasia. Dig Dis Sci (2013) 0.77
Application of quantitative estimates of fecal hemoglobin concentration for risk prediction of colorectal neoplasia. World J Gastroenterol (2013) 0.77
Small bowel evaluation in asymptomatic fecal immunochemical test-positive patients with a negative colonoscopy: is it necessary? Dig Dis Sci (2011) 0.77
What is the role of iFOBT in screening for colorectal cancer? Gut (2007) 0.77
Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse. World J Gastroenterol (2016) 0.75
The performance of three-sample qualitative immunochemical fecal test to detect colorectal adenoma and cancer in gastrointestinal outpatients: an observational study. PLoS One (2014) 0.75
Free Fecal Immunochemical Test Disbursement in Eight Family Physician Offices. J Community Health (2015) 0.75
Quantitative immunochemical fecal occult blood test for diagnosing colorectal neoplasia. Ann Intern Med (2007) 0.75
Fecal immunochemical test for colorectal cancer from a prospective cohort with 513,283 individuals: Providing detailed number needed to scope (NNS) before colonoscopy. Medicine (Baltimore) (2016) 0.75
Correlating Quantitative Fecal Immunochemical Test Results with Neoplastic Findings on Colonoscopy in a Population-Based Colorectal Cancer Screening Program: A Prospective Study. Can J Gastroenterol Hepatol (2016) 0.75
Proposed score for the self-assessment of an endoscopy department performance in colonoscopy screening. Clujul Med (2017) 0.75
Detection of fecal interferon-induced transmembrane protein messenger RNA for colorectal cancer screening. Oncol Lett (2010) 0.75
Predicting the progress of colon cancer by DNA methylation markers of the p16 gene in feces - Evidence from an animal model. Genet Mol Biol (2013) 0.75
Cost-Effectiveness between Double and Single Fecal Immunochemical Test(s) in a Mass Colorectal Cancer Screening. Biomed Res Int (2016) 0.75
Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model. BMC Public Health (2017) 0.75
Screening for colorectal cancer using a quantitative immunochemical faecal occult blood test: a feasibility study in an Asian population. Tech Coloproctol (2009) 0.75
Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials. JAMA (2008) 3.09
The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40-80 years. Am J Gastroenterol (2006) 2.34
Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy. J Allergy Clin Immunol (2010) 2.22
Familial adenomatous polyposis. Orphanet J Rare Dis (2009) 2.21
Pulmonary alveolar hemorrhage in a patient with ulcerative colitis and primary sclerosing cholangitis. Isr Med Assoc J (2002) 2.06
Screening colonoscopy for colorectal cancer in asymptomatic people: a meta-analysis. Dig Dis Sci (2008) 2.03
Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population study. Liver Int (2006) 1.96
Assessment and validation of the new capsule endoscopy Crohn's disease activity index (CECDAI). Dig Dis Sci (2007) 1.96
Helicobacter pylori recurrence in developed and developing countries: meta-analysis of 13C-urea breath test follow-up after eradication. Helicobacter (2008) 1.83
Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, NSAIDs, and anticoagulants. Am J Gastroenterol (2009) 1.80
The effect of herbal remedies on the production of human inflammatory and anti-inflammatory cytokines. Isr Med Assoc J (2002) 1.74
Mucin function in inflammatory bowel disease: an update. J Clin Gastroenterol (2013) 1.55
Does a colonoscopy after acute diverticulitis affect its management?: a single center experience. J Clin Gastroenterol (2012) 1.50
Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol (2002) 1.49
Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol (2005) 1.45
Large-scale population analysis reveals an extremely low threshold for "non-healthy" alanine aminotransferase that predicts diabetes mellitus. J Gastroenterol Hepatol (2010) 1.44
Eradication of Helicobacter pylori can be accurately confirmed 14 days after termination of triple therapy using a high-dose citric acid-based 13C urea breath test. Digestion (2005) 1.44
Body mass index and socioeconomic status measured in adolescence, country of origin, and the incidence of gastroesophageal adenocarcinoma in a cohort of 1 million men. Cancer (2013) 1.43
Helicobacter pylori recurrence and infection rate in Israeli adults. Dig Dis Sci (2007) 1.43
Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer. Gastroenterology (2008) 1.43
Predictors of specialized intestinal metaplasia in patients with an incidental irregular Z line. Eur J Gastroenterol Hepatol (2010) 1.41
It's time to choose the study design!: net benefit analysis of alternative study designs to acquire information for evaluation of health technologies. Pharmacoeconomics (2007) 1.38
The prevalence and natural course of food protein-induced enterocolitis syndrome to cow's milk: a large-scale, prospective population-based study. J Allergy Clin Immunol (2011) 1.34
Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully responded. J Neurogastroenterol Motil (2011) 1.32
MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol (2011) 1.29
Application of Maastricht 2-2000 guidelines for the management of Helicobacter pylori among specialists and primary care physicians in israel: are we missing the malignant potential of Helicobacter pylori? J Clin Gastroenterol (2004) 1.27
Incidence and management of colonoscopic perforations: 8 years' experience. World J Gastroenterol (2006) 1.23
Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial. Gastroenterology (2006) 1.21
A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol (2006) 1.21
Chronic urticaria and autoimmunity: associations found in a large population study. J Allergy Clin Immunol (2012) 1.21
Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected? Clin Infect Dis (2009) 1.19
Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study. Clin Cancer Res (2006) 1.18
PET/CT enterography in Crohn disease: correlation of disease activity on CT enterography with 18F-FDG uptake. J Nucl Med (2010) 1.06
Preparation for colonoscopy in hospitalized patients. Dig Dis Sci (2007) 1.04
Molecular analysis of the APC gene in 71 Israeli families: 17 novel mutations. Hum Mutat (2002) 1.03
Ion channel TRPV1-dependent activation of PTP1B suppresses EGFR-associated intestinal tumorigenesis. J Clin Invest (2014) 1.02
Cost-effectiveness analysis of screening for celiac disease in the adult population. Med Decis Making (2006) 1.00
Celecoxib leads to G2/M arrest by induction of p21 and down-regulation of cyclin B1 expression in a p53-independent manner. Eur J Cancer (2006) 0.99
Efficiency of bowel preparation for capsule endoscopy examination: a meta-analysis. World J Gastroenterol (2008) 0.99
Resistance of Helicobacter pylori isolated in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefixime. J Antimicrob Chemother (2002) 0.98
Endoscopy in asymptomatic minidose aspirin consumers. Dig Dis Sci (2005) 0.98
The role of video capsule endoscopy in the diagnosis of celiac disease: a meta-analysis. Eur J Gastroenterol Hepatol (2012) 0.98
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification. World J Gastroenterol (2013) 0.98
Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancer. Int J Oncol (2012) 0.97
Sesame food allergy and sensitization in children: the natural history and long-term follow-up. Pediatr Allergy Immunol (2007) 0.97
A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease. PLoS One (2013) 0.97
Evaluation of an automated immunochemical fecal occult blood test for colorectal neoplasia detection in a Chinese population. Cancer (2003) 0.97
BAT monoclonal antibody immunotherapy of human metastatic colorectal carcinoma in mice. Cancer Lett (2005) 0.96
The impact of EHR and HIE on reducing avoidable admissions: controlling main differential diagnoses. BMC Med Inform Decis Mak (2013) 0.96
Measured body mass index in adolescence and the incidence of colorectal cancer in a cohort of 1.1 million males. Cancer Epidemiol Biomarkers Prev (2011) 0.96
Susceptibility of Helicobacter pylori isolates to the antiadhesion activity of a high-molecular-weight constituent of cranberry. Diagn Microbiol Infect Dis (2004) 0.95
Inverse association between Helicobacter pylori and pediatric asthma in a high-prevalence population. Helicobacter (2012) 0.94
Cross-sensitization between milk proteins: reactivity to a "kosher" epitope? Isr Med Assoc J (2008) 0.94
Cumulative evaluation of a quantitative immunochemical fecal occult blood test to determine its optimal clinical use. Cancer (2010) 0.93
Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel. Cancer (2009) 0.93
Decision analysis supports the paradigm that indiscriminate supplementation of vitamin E does more harm than good. Arterioscler Thromb Vasc Biol (2009) 0.93
Colonic anastomosis performed with a memory-shaped device. Am J Surg (2005) 0.93
H pylori recurrence after successful eradication. World J Gastroenterol (2008) 0.92
Colon cancer cells expressing cell surface GRP78 as a marker for reduced tumorigenicity. Cell Oncol (Dordr) (2012) 0.92
Upper and Lower Gastrointestinal Findings in PTEN Mutation-Positive Cowden Syndrome Patients Participating in an Active Surveillance Program. Clin Transl Gastroenterol (2011) 0.91
Trends in colorectal cancer incidence and mortality in the Israeli Jewish ethnic populations. Fam Cancer (2004) 0.90
Psoriasis associated with hepatitis C but not with hepatitis B. Dermatology (2010) 0.90
Evaluation of a desk top instrument for the automated development and immunochemical quantification of fecal occult blood. Med Sci Monit (2006) 0.90
Long-term treatment outcome of patients with gastric vascular ectasia treated with argon plasma coagulation. Eur J Gastroenterol Hepatol (2014) 0.89
A protocol for genetic evaluation of patients with multiple colorectal adenomas and without evidence of APC gene mutation. Isr Med Assoc J (2010) 0.89
Surgical clip found in duodenal ulcer after laparoscopic cholecystectomy. Surg Laparosc Endosc Percutan Tech (2003) 0.88
Factors affecting compliance in faecal occult blood testing: a cluster randomized study of the faecal immunochemical test versus the guaiac faecal occult test. J Med Screen (2011) 0.87
Applying data mining techniques in the development of a diagnostics questionnaire for GERD. Dig Dis Sci (2007) 0.87
The role of duodenal bulb biopsy in the diagnosis of celiac disease in children. J Clin Gastroenterol (2011) 0.87
Natural course and risk factors for persistence of IgE-mediated cow's milk allergy. J Pediatr (2012) 0.86
Outcome of percutaneous endoscopic gastrostomy (PEG): comparison of two policies in a 4-year experience. Clin Nutr (2004) 0.86
Effect of proton pump inhibitors on the continuous real time (13)C-urea breath test. Am J Gastroenterol (2003) 0.85
Prevalence of symptoms suggestive of gastroparesis in a cohort of patients with diabetes mellitus. J Diabetes Complications (2013) 0.85
Gastric mucin expression in Helicobacter pylori-related, nonsteroidal anti-inflammatory drug-related and idiopathic ulcers. World J Gastroenterol (2012) 0.85